CXCL13 and encephalitis: The increased concentration of CSF CXCL13 in patients with anti-NMDAR encephalitis is associated with the synthesis of intrathecal anti-NMDAR antibodies, and thus, it may be a possible biomarker for evaluating the treatment response and prognosis (33, 70).